✦ LIBER ✦

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

✍ Scribed by Drury, S. C.; Detre, S.; Leary, A.; Salter, J.; Reis-Filho, J.; Barbashina, V.; Marchio, C.; Lopez-Knowles, E.; Ghazoui, Z.; Habben, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NHERF1: molecular brake on the PI3K path

✍ Maria-Magdalena Georgescu 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 43 KB

The PI3K/AKT/mTOR Signaling Pathway: Imp

✍ Eleni Andreopoulou 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Defining biomarkers to predict sensitivi

✍ Gonzalez-Angulo, A.M.; Blumenschein, G.R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Tamoxifen in the Treatment of Breast Can

✍ Wood, Alastair J.J.; Osborne, C. Kent 📂 Article 📅 1998 🏛 Massachusetts Medical Society 🌐 English ⚖ 141 KB

Reducing the Risk for Breast Cancer Recu

✍ Mohammad Jahanzeb 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Targeting the PI3K/AKT/mTOR pathway in e

✍ Ciruelos Gil, Eva Maria 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 653 KB